Annals of Clinical Neurophysiology

  • 제25권2호
  • /
  • Pages.106-109
  • /
  • 2023
  • /
  • 2508-691X(pISSN)
  • /
  • 2508-6960(eISSN)
대한임상신경생리학회 (The Korean Society of Clinical Neurophysiology)
권호 표지
DOI QR코드

DOI QR Code

Inclusion body myositis accompanied with T-cell large granular lymphocyte leukemia

  • Dong-Young Jeong (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seung-Hee Lee (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Jungmin So (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ji Yon Kim (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Young Chul, Kim (Department of Plastic and Reconstructive Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Miyoung Kim (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Eun-Ji Choi (Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Eun-Jae Lee (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hyung Jun Park (Department of Neurology, Gangnam Severance Hospital, Yonsei University College of Medicine) ;
  • Young-Min Lim (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Hyunjin Kim (Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine)
  • 투고 : 2023.08.02
  • 심사 : 2023.10.11
  • 발행 : 2023.10.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Inclusion body myositis (IBM) is a late-onset myopathy that manifests as distinct muscle weakness in the quadriceps, finger flexors, and ankle dorsiflexors. T-cell large granular lymphocyte (T-LGL) leukemia is a late-onset clonal disorder of CD8+ cytotoxic T-cells that is often accompanied by autoimmune diseases. To date, the association between IBM and T-LGL leukemia has been infrequently reported. Here, we report a case of a patient with T-LGL leukemia who developed IBM, along with in-depth laboratory, electrophysiological, and pathologic findings.

키워드

과제정보

This study was supported by grants from Asan Institute for Life Science, Asan Medical Center, Seoul, South Korea (2023IP0107).

참고문헌

  1. Rose MR. 188th ENMC international workshop: inclusion body myositis, 2-4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 2013;23:1044-1055. https://doi.org/10.1016/j.nmd.2013.08.007
  2. Lloyd TE, Mammen AL, Amato AA, Weiss MD, Needham M, Greenberg SA. Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology 2014;83:426-433. https://doi.org/10.1212/WNL.0000000000000642
  3. Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol 1984;16:209-215. https://doi.org/10.1002/ana.410160207
  4. Mastaglia FL, Needham M, Scott A, James I, Zilko P, Day T, et al. Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype. Neuromuscul Disord 2009;19:763-765. https://doi.org/10.1016/j.nmd.2009.07.015
  5. Larman HB, Salajegheh M, Nazareno R, Lam T, Sauld J, Steen H, et al. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 2013;73:408-418. https://doi.org/10.1002/ana.23840
  6. Arnardottir S, Ansved T, Nennesmo I, Borg K. Report of a patient with inclusion body myositis and CD8+ chronic lymphocytic leukaemia--post-mortem analysis of muscle and brain. Acta Neurol Scand 2001;103:131-135. https://doi.org/10.1034/j.1600-0404.2001.103002131.x
  7. Greenberg SA, Pinkus JL, Amato AA, Kristensen T, Dorfman DM. Association of inclusion body myositis with T cell large granular lymphocytic leukaemia. Brain 2016;139:1348-1360. https://doi.org/10.1093/brain/aww024
  8. Greenberg SA, Pinkus JL, Kong SW, Baecher-Allan C, Amato AA, Dorfman DM. Highly differentiated cytotoxic T cells in inclusion body myositis. Brain 2019;142:2590-2604. https://doi.org/10.1093/brain/awz207
  9. Greenberg SA. Inclusion body myositis: clinical features and pathogenesis. Nat Rev Rheumatol 2019;15:257-272. https://doi.org/10.1038/s41584-019-0186-x
  10. Askanas V, Engel WK, Nogalska A. Sporadic inclusion-body myositis: a degenerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy. Biochim Biophys Acta 2015;1852:633-643. https://doi.org/10.1016/j.bbadis.2014.09.005